Shares of Bio-Techne Corp. TECH slipped 5.72% to $51.72 Friday, on what proved to be an all-around rough trading session for ...

Shares of Bio-Techne Corp. TECH shed 6.03% to $54.86 Thursday, on what proved to be an all-around dismal trading session for ...

Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research ...

Shareholders of Bio-Techne would probably like to forget the past six months even happened. The stock has dropped 26.9% and ...

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else ...

Bio-Techne (TECH) announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics, or ACD, ...

In a report released on April 1, Conor McNamara from RBC Capital maintained a Hold rating on Bio-Techne (TECH – Research Report), with a price ...

Bio-Techne Corporation TECH recently opened a new Customer Experience Centre in Düsseldorf, Germany, to serve customers across the Europe, Middle East and Africa (“EMEA”) region. The facility ...

(RTTNews) - Bio-Techne Corp. (TECH), Wednesday announced expanded collaboration between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a provider of anatomic ...

Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet ...

MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care ...